|
|
||||||||
1Laboratoire de bactériologie, faculté de pharmacie, 15, avenue Charles Flahault, 34093 Montpellier Cedex 5, France 2Laboratoire de bactériologie, hôpital Arnaud de Villeneuve, 34295 Montpellier Cedex 5, France 3Laboratoire de bactériologie, hôpital Carremeau, 30060 îmes, France
Correspondence Estelle Jumas-Bilak ebilak{at}univ-montp1.fr
Received April 10, 2005
Accepted July 6, 2005
Among the six species characterized within the genus Ochrobactrum, Ochrobactrum anthropi and Ochrobactrum intermedium are currently reported as opportunistic pathogens in humans. Since the species identification is mainly based on 16S rDNA analysis, the aim of this study was to search for other characteristics useful for Ochrobactrum species discrimination. Ribotyping, morphological and biochemical analyses, and antimicrobial susceptibility testing were performed for a panel of 35 clinical isolates, first identified to the species level using 16S rDNA sequencing. Type and reference strains of five Ochrobactrum species were comparatively analysed. Commercial identification systems such as API 20NE and VITEK 2 were tested for their ability to identify Ochrobactrum anthropi and to detect other members of the genus Ochrobactrum. An improved protocol for the identification of Ochrobactrum spp. by routine medical microbiology practices is proposed: isolation of a non-fastidious non-fermenting oxidase-positive Gram-negative rod resistant to all ß-lactams except imipenem indicates the genus Ochrobactrum, and the API 20NE system confirms the genus identification for most strains, whereas the VITEK 2 system using ID-GNB cards was less powerful. Urease activity, the mucoidy of the colonies, growth at 45 °C on tryptic soy agar, and susceptibility to colistin, tobramycin and netilmicin should be considered as differential characteristics for identification of O. anthropi and O. intermedium to the species level. However, definitive identification depends on genotyping methods.
The GenBank/EMBL/DDBJ accession numbers for the 16s rDNA sequences reported in this paper are AF526518AF526526, AY917104AY917119 and AY918295AY918296.
| INTRODUCTION |
|---|
|
|
|---|
-subgroup of proteobacteria, closely related to the genus Brucella (Lebuhn et al., 2000; Velasco et al., 1998). Surprisingly, 16S rDNA-based phylogeny, as well as protein profiling (Velasco et al., 1998) and AFLP analysis (Leal-Klevezas et al., 2005), place O. intermedium strains closer to Brucella spp. than any other members of the genus Ochrobactrum. O. anthropi has been isolated from various clinical specimens and is recognized as an opportunistic pathogen. Nosocomial infections due to O. anthropi have been increasingly reported during the last decade, particularly bacteraemia and endocarditis in patients with indwelling central venous catheters (Gill et al., 1997; Mahmood et al., 2000; Stiakaki et al., 2002). Other cases of infections and outbreaks have been described in patients in dialysis (see Daxboeck et al., 2002 for a review), after surgery in ophthalmology (Berman et al., 1997; Greven & Nelson, 2001; Inoue et al., 1999), in neurosurgery (Christenson et al., 1997), after transplantation (Ezzedine et al., 1994), or after valve replacement (Romero Gomez et al., 2004). The virulence of O. anthropi is generally considered to be low, but reports suggested a high virulence for some strains involved in pyogenic infections (Brivet et al., 1993; Cieslak et al., 1996; Wheen et al., 2002). O. anthropi was described as one of the most antibiotic-resistant Gram-negative rods (Nadjar et al., 2001; Higgins et al., 2001). Indeed, clinical strains of O. anthropi are multiresistant to common antibiotics, in particular they are usually resistant to all ß-lactams except imipenem. The resistance to ß-lactams is explained by the presence of an AmpC ß-lactamase described as chromosomal, inducible and resistant to inhibition by clavulanic acid (Nadjar et al., 2001). The majority of Ochrobactrum infections in humans have been imputed to the species O. anthropi, except for a liver abscess caused by O. intermedium (Moller et al., 1999).
The aim of this study was to determine genotypic and phenotypic features allowing discrimination between the Ochrobactrum species. We carried out comparative analyses of 35 clinical isolates to type or reference strains of O. anthropi, O. intermedium, O. tritici, O. grignonense and O. gallinifaecis. O. lupini' was not included in the study due to its very recent description (Trujillo et al., 2005). Comparative analysis with clinically relevant
-proteobacterial genera, such as Brucella, Agrobacterium, Sinorhizobium and Inquilinus is also presented. The isolates were first identified by 16S rDNA sequencing and analysed by ribotyping. Then, we studied cell and colony morphology, growth conditions, biochemical traits on commercial identification systems, and antibiotic susceptibility, in order to define characteristics that could be used for species identification in a routine medical microbiology protocol.
| METHODS |
|---|
|
|
|---|
16S rRNA gene analysis.
Bacteria were grown on tryptic soy agar (TSA) for 24 h at 37 °C. One colony was suspended in 50 µl sterile water, and the DNA was liberated by a boiling-freezing method (Teyssier et al., 2003). The 16S rRNA gene was selectively amplified from this crude lysate by PCR using universal primers 27f and 1492r, as previously described (Teyssier et al., 2003). PCR products of about 1400 bp were sequenced directly on an Applied Biosystems Automatic Sequencer (Genome Express). Partial 16S rDNA sequences were compared with sequences deposited in databases using the standard nucleotide-nucleotide Basic Local Alignment Search Tool (BLAST) program (http://www.ncbi.nlm.nih.gov/blast/). The genetic distances between strains were calculated using the DNADIST program (option similarity table) in the PHYLIP package (www.pasteur.fr) after sequence alignment by the DIALIGN software (www.expasy.org).
Ribotyping.
Intact genomic DNAs were prepared in agarose plugs for enzymic digestion as previously described (Teyssier et al., 2003). DNAs were digested with 40 U HindIII or EcoRI (New England Biolabs), and then electrophoresed for 3 h at 80 V in a 0.8 % agarose gel in 0.5x TBE. Gels were transferred onto nylon membrane by vacuum blotting (vacuum blotter; Bio-Rad) in 20x SSC. The 16S rDNA digoxigenin (DIG)-labelled probe was obtained by PCR using the 27f/1492r pair of primers with a dNTPs mixture containing 0.1 mM DIG-dUTP (Roche), and with the DNA of O. intermedium LMG 3301T as a template. The hybridization of the probe was detected by the CSPD chemiluminescent system (Roche).
Phenotypic analysis.
Cultures were grown at 30, 37 and 45 °C on TSA, blood Columbia agar (bioMérieux), cetrimide agar, Drigalski medium and MacConkey medium (Difco BRL) for 24 h. Cell morphology was observed by photonic microscopy after Gram staining. Identification systems API 20E, API 20NE and VITEK 2, ID-GNB card version WSVT2-R03.01 (bioMérieux), were used according to the supplier's recommendations, and particular care was taken to obtain the recommended turbidity for the bacterial suspensions. Urease activity was detected after bacterial growth on urea-indole medium (bioMérieux). The strain's susceptibility to antibiotics was determined by the disk-diffusion assay on MuellerHinton agar, according to the guidelines of the Comité de l'Antibiogramme de la Société Fraçaise de Microbiologie (Members of the SFM Antibiogram Committee, 2003). The antibiotic disks (Bio-Rad) used were as follows: amoxycillin (25 µg), amoxycillin/clavulanic acid (20 µg/10 µg), ticarcillin (75 µg), ticarcillin/clavulanic acid (75 µg/10 µg), piperacillin (75 µg), piperacillin/tazobactam (75 µg/10 µg), imipenem (10 µg), cefalotine (30 µg), cefotaxime (30 µg), ceftazidime (30 µg), cefpirome (30 µg), cefepime (30 µg), latamoxef (30 µg), aztreonam (30 µg), gentamicin (15 µg ), tobramycin (10 µg), netilmicin (30 µg), nalidixic acid (30 µg), pefloxacin (5 µg), ofloxacin (5 µg), ciprofloxacin (5 µg), rifampicin (30 µg), colistin (50 µg), chloramphenicol (30 µg) and trimethoprim/sulfamethoxazole (1.25 µg/23.75 µg).
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
|
|
|
|
Phenotypic traits of Ochrobactrum spp.
All the strains were Gram-negative short rods, straight or slightly curved with one end flame shaped. Wet-mount microscopy examination showed that the cells were highly motile. After 24 h incubation, colony aspect at 30 and 37 °C on TSA, Drigalski medium and MacConkey medium clearly differed among species. O. anthropi and O. grignonense developed circular, smooth, shiny colonies, whereas the colonies of O. intermedium and O. tritici were mucoid, opaque and quickly became confluent. The strains of O. intermedium were the sole strains able to grow at 45 °C on TSA. No strain grew on cetrimide agar. Haemolysis was never observed on blood Columbia agar. The brown pigment classically described for the genus Ochrobactrum was hardly visible on TSA and blood Columbia agar, even when a colony was harvested on a swab.
Using the API 20E and API 20NE systems, all the strains were negative for indole, H2S and acetoin production, carbohydrate fermentation, utilization of citrate, and assimilation of adipate and phenylacetate. Moreover, arginine dihydrolase, lysine decarboxylase, ornithine decarboxylase, ß- galactosidase and gelatinase activities were not detected. All the strains were positive for the assimilation of glucose, arabinose, mannose, N-acetylglucosamine, maltose and malate. Other characteristics varied among strains of a same species except for urease activity. Positive urease activity, detected either by urea-indole medium (bioMérieux) or on API strips was shown for all O. anthropi except strain ADV 45, and for O. tritici and O. gallinifaecis strains. In contrast, none of the O. intermedium and O. grignonense strains displayed urease activity, whatever the method used to detect it (Table 3). However, an inoculum heavier than that recommended by manufacturers led to positive reactions for most of these strains. The VITEK 2 ID-GNB card gave urease results consistent with the urea-indole medium and the API systems, except for the results for three strains of O. intermedium (strains ADV1, ADV14 and ADV36), which showed urease activity only when analysed on the VITEK 2 apparatus. All these discrepancies suggested that O. intermedium possessed a faint urease activity as previously underlined by Lebuhn et al. (2000). This could explain the discrepancy observed between the urease activity results reported for O. intermedium in previous studies (Lebuhn et al., 2000; Moller et al., 1999; Velasco et al., 1998). Urease activity should no longer be considered as a criterion for genus identification, but rather as a biochemical characteristic useful for the discrimination of the two Ochrobactrum species of medical interest, O. anthropi and O. intermedium.
|
Only a few of the 41 characteristics tested by the ID-GNB card of the VITEK 2 system were positive for Ochrobactrum spp. Pyrrolidonyl arylamidase (PyrA), L-proline arylamidase (ProA) and alkaline phosphatase (PHOS) had been previously described as very useful tests for the identification of non-fermenting Gram-negative rods (Laffineur et al., 2002). The authors found that 100 % of the Ochrobactrum spp. strains were positive for PyrA and ProA, and negative for PHOS. Our results were in accordance for PyrA (42+/42) and PHOS (42/42), but ProA was not positive for all strains (28+/42). The results for
-glutamyl transferase (17+/42), adonitol (17+/42), D-maltose (12+/42), palatinose (11+/42), sucrose (9+/42) and L-lysine arylamidase (5+/42) were variable between strains, without correlation with species identification. The glu-gly-arg arylamidase (GGAA) was positive for O. grignonense strains only, but additional strains of this species need to be tested to determine if it is a species-specific characteristic.
Comparison of API 20NE strip and VITEK 2 ID-GNB card for Ochrobactrum identification
It should be noted that O. anthropi is the sole species of the genus Ochrobactrum included in the databases of the API and VITEK 2 systems. Using the API 20NE system, nearly all the strains were identified as O. anthropi at 24 h, with the mention very good identificatio or excellent identificatio (Tables 1 and 2). The two O. grignonense strains were unidentified, or misidentified as Pseudomonas fluorescens with low discrimination. Moreover, the O. gallinifaecis type strain remained unidentified (Table 2). The reading of the strips after 48 h gave the same identification, but associated with the mentions good identificatio or acceptable identification'. Thus, despite the supplier's recommendations, the more confident identification of the genus was obtained after 24 h incubation of the strips. The absence of urease in O. intermedium strains did not alter the confidence level of identification, since urease was presented as an inconstant characteristic for O. anthropi (84 %) on the API 20NE technical sheet. It is likely that the original calibration of the system used O. anthropi strain samples that were actually a mix of O. anthropi and O. intermedium strains. Thus, the API 20NE system gave satisfactory identification of the genus Ochrobactrum, except for O. grignonense and O. gallinifaecis strains.
The identification reports given by the VITEK 2 system after analysis of the ID-GNB card are shown in Tables 1 and 2. In 8 cases out of 42, the identification of O. anthropi was assessed with the following confidence levels: excellent identificatio (n = 2), very good identificatio (n = 3), good identificatio (n = 1), and acceptable identificatio (n = 2). The identification of O. anthropi was proposed with a low discrimination for 16 strains; the identification of Pseudomonas aeruginosa is proposed as an alternative choice for nine of these. To sum up, the VITEK 2 gave or suggested the identification of O. anthropi for 25 strains among the 42 tested. This identification system appeared to be less powerful than the API 20NE system for the identification of the genus Ochrobactrum. Particularly, the VITEK 2 ID-GNB card gave the identification of Pseudomonas aeruginosa with the mention very good identificatio for 3 strains and did not achieve identification for 11 strains. The three misidentified isolates (ADV3, ADV9, ADV21) were readily identified, at least to the genus level, by using the API 20NE system (Table 2). The VITEK 2 proposed the name O. anthropi for 16 out of 21 O. anthropi strains, but for only 6 out of 16 O. intermedium strains. The two O. tritici strains were identified as O. anthropi, but O. grignonense and O. gallinifaecis strains were not identified. The results suggested that the VITEK 2 system placed urease as a major characteristic for identification. As a consequence, the species without detectable urease activity were not fully identified as members of the genus Ochrobactrum.
Antibiotic susceptibility testing
All the O. anthropi clinical isolates and the type strains were highly resistant to all ß-lactams except imipenem (no growth inhibition was observed for most of the ß-lactams). This resistance profile is consistent with the expression of the AmpC ß-lactamase characterized in O. anthropi (Higgins et al., 2001; Nadjar et al., 2001). Identical susceptibility patterns were obtained for the strains of O. intermedium and O. tritici, suggesting that a ß-lactamase of the same class, or the same enzyme, could be expressed in these two species. The two O. grignonense strains were also resistant to all ß-lactams except imipenem, but in contrast to the strains of O. anthropi, O. intermedium and O. tritici, growth inhibition was observed around amoxycillin (12 mm diameter), cefotaxime (20 mm diameter), cefpirome (15 mm diameter), cefepime (19 mm diameter) and latamoxef (20 mm diameter) disks. Moreover, the partial restoration of the amoxycillin and ticarcillin activities by clavulanic acid was not in agreement with the presence of a class 1 AmpC ß-lactamase. These observations suggested that the mechanism of resistance of O. grignonense differed from that of the three other species, but this needs further investigation. In contrast with all the other members of the genus, the type strain of O. gallinifaecis was susceptible to all ß-lactams except aztreonam.
We observed a general susceptibility of the strains to gentamicin, rifampicin and fluoroquinolones. Susceptibility to netilmicin and tobramycin varied according to the species. All the O. anthropi strains were susceptible to netilmicin and tobramycin, whereas all the O. intermedium strains were resistant to these aminoglycosides (Table 3). Moreover, we confirmed in our collection of 35 clinical isolates the susceptibility of O. anthropi to colistin, and the resistance of O. intermedium to this antibiotic, as reported by Velasco et al. (1998) (Table 3). Susceptibility to trimethoprim/ sulfamethoxazole was observed for all strains of O. anthropi, O. intermedium, O. tritici and O. gallinifaecis, whereas the two O. grignonense strains were resistant to this association. Moreover, the O. gallinifaecis type strain was the sole strain found to be susceptible to chloramphenicol.
Improving the identification of Ochrobactrum species in medical microbiology
An efficient procedure for identifying Ochrobactrum to the species level is necessary to evaluate the role of each species in human infections, as well as for epidemiological investigations. The results we obtained for isolates and type strains of O. anthropi and O. intermedium allowed us to propose a routine protocol for identifying these two Ochrobactrum species, which were currently the only ones involved in human pathology. Firstly, the isolation of a non-fastidious non-fermenting Gram-negative rod, which is oxidase-positive and resistant to all ß-lactams except for imipenem should indicate both the genera Ochrobactrum and Inquilinus (Coenye et al., 2002). However, Inquilinus spp. displays a remarkably huge inhibition diameter (4060 mm) around an imipenem disk (Chiron et al., 2005). In addition, I. limosus can be differentiated from Ochrobactrum spp. by its growth on Drigalski agar but not on MacConkey agar plates. Although Brucella spp. and Ochrobactrum spp. are genetically very closely related, they show clear differences in their phenotypes, i.e. Brucella spp. are fastidious and slow-growing Gram-negative cocco-bacilli.
Secondly, commercial identification systems can confirm the genus identification. Members of the genera Agrobacterium and Sinorhizobium were both identified by the API 20NE system as Agrobacterium radiobacter with a high level of confidence (Table 2). The use of the API 20NE system gave, for most of the strains tested, the identification of O. anthropi. Since O. intermedium is not included in the commercial identification systems databases, the identification of O. anthropi ought to be considered as genus identification. The VITEK 2 system appeared to be less efficient than the API 20NE system at identifying the genus Ochrobactrum. However, the newly available VITEK 2 detection system (VITEK 2 Advanced Colorimetry) needs to be evaluated. For routine identification to the species level, the urease test should be taken into account as a good indication (Table 3). Then, the aspect of the colonies, their growth at 45 °C on TSA and their susceptibility to colistin, tobramycin and netilmicin should be considered as additional characteristics allowing the species identification (Table 3).
We cannot propose a robust methodology for the identification of O. tritici, O. grignonense and O. gallinifaecis due to the low number of isolates characterized to date for these species. However, the preliminary results suggest that O. tritici strains are readily identified as members of the genus Ochrobactrum by the use of an API 20NE strip. The two strains are highly related to O. anthropi, with a positive urease test and susceptibility to colistin, netilmicin and tobramycin, but they differ from this species by their highly mucoid colonies on TSA. The criteria for differentiating O. grignonense and O. gallinifaecis from other members of the genus are given in Table 3. However, their genus affiliation is hard to assign since identification systems fail to class them as members of the genus Ochrobactrum, and their ß-lactam resistance patterns are atypical. Therefore, O. grignonense and O. gallinifaecis can only be readily identified by molecular means.
Conclusion
To our knowledge, we have presented here the largest collection of Ochrobactrum spp. clinical isolates identified to the species level by genotyping methods. The literature included only one case of human infection caused by O. intermedium (Moller et al., 1999), suggesting that amongst Ochrobactrum species O. anthropi has the predominant role in human disease. However, most of the infections involving O. anthropi were reported before the description of the other Ochrobactrum species, and/or by the use of non-discriminating methods. Thus, the role of each species in human infections needs to be revisited. Our collection showed a nearly equivalent distribution of clinical isolates between O. anthropi and O. intermedium. This indicates that the role of O. intermedium in human infections is probably underestimated due to the lack of a convenient identification system and should be further evaluated.
The phenotypic study of the collection allowed us to determine some characteristics useful for species identification using routine medical microbiology. However, further large-scale studies including more isolates are clearly required to confirm the efficiency of our approach for the identification of Ochrobactrum spp. More generally, this study could be considered as an improvement of the identification of Gram-negative non-fermenting rods by conventional methods. Indeed, their identification is often difficult, and the commercial systems are not always reliable, especially for some genera and species (Laffineur et al., 2002; VanPelt et al., 1999). Moreover, recent taxonomic studies resulted in the description of an increasing number of new taxa involved in nosocomial infections, and requiring additional tests for identification. This was particularly true for the genus Ochrobactrum.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. M. Shilton, G. P. Brown, S. Benedict, and R. Shine Spinal Arthropathy Associated with Ochrobactrum anthropi in Free-ranging Cane Toads (Chaunus [Bufo] marinus) in Australia Vet. Pathol., January 1, 2008; 45(1): 85 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Scholz, M. Pfeffer, A. Witte, H. Neubauer, S. Al Dahouk, U. Wernery, and H. Tomaso Specific detection and differentiation of Ochrobactrum anthropi, Ochrobactrum intermedium and Brucella spp. by a multi-primer PCR that targets the recA gene J. Med. Microbiol., January 1, 2008; 57(1): 64 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kampfer, D. M. Citron, E. J. C. Goldstein, and H. C. Scholz Difficulty in the identification and differentiation of clinically relevant Ochrobactrum species J. Med. Microbiol., November 1, 2007; 56(11): 1571 - 1573. [Full Text] [PDF] |
||||
![]() |
C. Teyssier, H. Marchandin, H. Jean-Pierre, A. Masnou, G. Dusart, and E. Jumas-Bilak Ochrobactrum pseudintermedium sp. nov., a novel member of the family Brucellaceae, isolated from human clinical samples Int J Syst Evol Microbiol, May 1, 2007; 57(5): 1007 - 1013. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |